VAERS reports by lot

GSK Varicella/Shingles lot ZG47A: VAERS reports

78 VAERS reports list lot ZG47A as a GSK Varicella/Shingles vaccine, received between 2018-07-18 and 2021-08-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
78
Reports
3%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)8627%
Injection-site / Local reaction8426%
Musculoskeletal4113%
Neurological3110%
Dermatological (non-injection-site)278%
Cardiac / Cardiovascular155%
Gastrointestinal155%
Allergic / Anaphylactic124%
Psychiatric / Neuropsychiatric72%
Respiratory41%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
Ohio8
Colorado7
Michigan5
Pennsylvania4
Kentucky4
Virginia4
West Virginia4
Tennessee3
Iowa3
Minnesota3
Florida2

Reports by month received

2018-0725
2018-0826
2018-099
2018-105
2018-112
2018-123
2019-013
2019-021
2019-041
2019-051
2019-081
2021-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.